Get started
Author

William Otero

Observed names: W Otero, W. Otero
Observed institution: Universidad Nacional de Colombia
OpenAlex ID: A5075855325
Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational study
2023 · Juan M. Reyes, Magda V. Gutierrez‐Ardila, et al. · Health Science Reports · 4
PDF
Clinical practice guideline for the diagnosis and management of adult patients with Ulcerative Colitis
2015 · Fabián Juliao Baños, Carlos Fernando, et al. · Redalyc (Universidad Autónoma del Estado de México) · 2
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries
2023 · J.M. Reyes, M.V. Gutierrez, et al. · Reumatología Clínica (English Edition) · 1
Colitis por desviación
2007 · Maria Valete-Rosalino Claudia, Guillermo Quiroga, et al. · Redalyc (Universidad Autónoma del Estado de México) · 1
P1028 Impact of upadacitinib on defaecatory urgency in ulcerative colitis: real-world data from Colombia
2026 · L V Parra Izquierdo, F Juliao Baños, et al. · Journal of Crohn s and Colitis
PDF
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries
2023 · J.M. Reyes, M.V. Gutierrez, et al. · Reumatología Clínica
Work productivity in rheumatoid arthritis patients from two Latin American countries treated with tofacitinib or biological DMARDs
2022 · MV Gutierrez-Ardila, Jm Reyes, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
Works count: 7
Citation count: 8
H-index: 2
I10-index:
Year
Topic
Type